EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Pharmacogenetics of selective serotonin reuptake inhibitors (SSRI): A serotonin reuptake transporter (SERT)-based approach

V Sreeja, Anju Jose, Shashikant Patel, Bindu Menon, K V Athira, Sumana Chakravarty

Neurochemistry International · 2024-02 · 173 · 105672

DOI: 10.1016/j.neuint.2023.105672 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Neurochemistry International, 2024-02. Verfasst von V Sreeja und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, Amrita School of Pharmacy, Amrita Vishwa Vidyapeetham, AIMS Health Sciences Campus, Kochi, 682 041, Kerala, India. Hauptthemen laut MEDLINE: Selective Serotonin Reuptake Inhibitors, Serotonin. Die Arbeit wurde bisher 28-mal zitiert (Crossref) und nennt 139 Literaturangaben. Gefördert von: Council of Scientific and Industrial Research, India, Amrita Vishwa Vidyapeetham University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Neuropsychiatric disorders are considered to be the most common cause of disability worldwide. Serotonin and its transporter is a prominent paradigm in mood disorders. Response to selective serotonin reuptake inhibitors (SSRI) is altered due to heterogeneity in the serotonin transporter gene, SLC6A4 (solute carrier family 6 member 4). The reported polymorphisms are found to be in different regions of the transporter gene: promoter region (5-HTTLPR and various single nucleotide polymorphisms within it), intron (STin2), and exon 9 (I425V). The long and short alleles of the 5-HTTLPR gene, which are prevalent among variations, may mediate differential effects. In long allelic variant carriers, an increased response to SSRI and timely recovery is due to increased availability of SERT. Whereas, SERT availability is significantly decreased in short allelic carriers, necessitating a reduction in SSRI dosage due to the increased risk of adverse drug reactions. Thus, pharmacogenetic investigations are required to understand the impact of functional variations on the efficacy and tolerability of SSRI. Identifying the carrier variants may aid in clear-decision making of the treatment regimen, aiding the approach of personalized medication.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Selective Serotonin Reuptake InhibitorsSerotoninPharmacogeneticsSerotonin Plasma Membrane Transport ProteinsPolymorphism, Single Nucleotide

Stichwörter der Autor:innen

DepressionGenetic polymorphismMood disordersNeuropsychiatryPharmacogeneticsSelective serotonin reuptake inhibitors

Substanzen

Selective Serotonin Reuptake InhibitorsSerotoninSerotonin Plasma Membrane Transport Proteins

Autor:innen und Institutionen

  • Department of Pharmacology, Amrita School of Pharmacy, Amrita Vishwa Vidyapeetham, AIMS Health Sciences Campus, Kochi, 682 041, Kerala, India.
  • Applied Biology Division, CSIR- Indian Institute of Chemical Technology, Tarnaka, Uppal Road, Hyderabad, 500007, Telangana, India; Academy of Scientific and Innovative Research (AcSIR), Ghaziabad, India.
  • Department of Psychiatry, Amrita School of Medicine, Amrita Vishwa Vidyapeetham, AIMS Health Sciences Campus, Kochi, 682 041, Kerala, India.
  • Department of Pharmacology, Amrita School of Pharmacy, Amrita Vishwa Vidyapeetham, AIMS Health Sciences Campus, Kochi, 682 041, Kerala, India. Electronic address: athirakv@pharmacy.aims.amrita.edu.
  • Applied Biology Division, CSIR- Indian Institute of Chemical Technology, Tarnaka, Uppal Road, Hyderabad, 500007, Telangana, India; Academy of Scientific and Innovative Research (AcSIR), Ghaziabad, India. Electronic addr…

Förderung

  • Council of Scientific and Industrial Research, India
  • Amrita Vishwa Vidyapeetham University

Zitieren

APA

Sreeja, V., Jose, A., Patel, S., Menon, B., Athira, K. V., & Chakravarty, S. (2024). Pharmacogenetics of selective serotonin reuptake inhibitors (SSRI): A serotonin reuptake transporter (SERT)-based approach. Neurochemistry International, 173, 105672. https://doi.org/10.1016/j.neuint.2023.105672

Vancouver

Sreeja V, Jose A, Patel S, Menon B, Athira KV, Chakravarty S. Pharmacogenetics of selective serotonin reuptake inhibitors (SSRI): A serotonin reuptake transporter (SERT)-based approach. Neurochemistry International. 2024;173:105672. doi:10.1016/j.neuint.2023.105672

BibTeX
@article{Sreeja2024,
  author = {Sreeja, V and Jose, Anju and Patel, Shashikant and Menon, Bindu and Athira, K V and Chakravarty, Sumana},
  title = {Pharmacogenetics of selective serotonin reuptake inhibitors (SSRI): A serotonin reuptake transporter (SERT)-based approach},
  journal = {Neurochemistry International},
  year = {2024},
  volume = {173},
  pages = {105672},
  doi = {10.1016/j.neuint.2023.105672}
}
Kostenlos starten →